Amnylin Surges 54% as Traders Bet on More Bids

Amnylin Surges 54% as Traders Bet on More Bids Play

March 29 (Bloomberg) -- Bloomberg's Julie Hyman reports that options traders are betting potential acquirers from AstraZeneca Plc to Bristol-Myers Squibb Co. will have to spend 26 percent more than its current price to buy Amylin Pharmaceuticals Inc. She speaks on Bloomberg Television's "InBusiness With Margaret Brennan."

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus